Primary Care Providers May Be Key to Faster Alzheimer’s Treatment
Widespread availability of effective disease-modifying therapies (DMTs) might be a breakthrough in slowing the progression of early-stage Alzheimer’s disease (AD) to later stages of dementia. An AD DMT has received traditional approval from the Food and Drug Administration, and more candidates are on the horizon. The authors used a simulation model to assess patient demand and provider supply for the delivery of AD DMTs. They expanded on prior modeling by including the capacity of primary care practitioners (PCPs) who perform brief cognitive assessments and by utilizing county-level data.
The results suggest that engaging the primary care workforce in the diagnostic process might be vital to accelerate the delivery of AD DMTs, which will overwhelm neurology and geriatric practices that often already have wait lists for appointments. Under the base case assumptions, the states with the longest wait times are Alaska, Arkansas, Idaho, Mississippi, Montana, Nevada, Oklahoma, and Wyoming. Primary care models and telehealth models can help improve access to care in these areas. Further work is needed to evaluate how primary care–led models of care can widely and effectively evaluate and manage treatment for people with early-stage AD, as well as how technological advancements, such as improved biomarkers and computerized testing, can be integrated into workflows.
This research was sponsored by Genentech and conducted within the Access and Delivery Program of RAND Health Care.
This report is part of the RAND research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors.
Disasters Expo USA, is proud to be supported by Inergency for their next upcoming edition on March 6th & 7th 2024!
The leading event mitigating the world’s most costly disasters is returning to the Miami Beach
And in case you missed it, here is our ultimate road trip playlist is the perfect mix of podcasts, and hidden gems that will keep you energized for the entire journey-